Neuromodulation + Cognitive Training for Traumatic Brain Injury
(CONNECT-TBI Trial)
What You Need to Know Before You Apply
What is the purpose of this trial?
This trial tests new methods to improve thinking skills in Veterans with mild traumatic brain injury (mTBI) who continue to struggle with focus or memory. It examines the combination of Attention Process Training, a cognitive training program, with various types of brain stimulation to determine the most effective approach. Veterans who may qualify for this trial are those who sustained a mild brain injury between 3 months and 5 years ago and experience ongoing cognitive difficulties. As an unphased trial, it provides Veterans the chance to explore innovative treatments that could enhance cognitive recovery.
Will I have to stop taking my current medications?
The trial requires that participants have been on stable doses of any psychotropic medications for the past 2 months, so you won't need to stop taking them if they have been stable.
Is there any evidence suggesting that this trial's treatments are likely to be safe?
Research shows that both repetitive transcranial magnetic stimulation (rTMS) and high-definition transcranial direct current stimulation (HD-tDCS) have undergone safety testing in people with traumatic brain injuries.
For rTMS, studies have found it generally well-tolerated. Safety checks revealed no serious side effects in patients with brain injuries. Some individuals might experience mild side effects like headaches or scalp discomfort, but these usually resolve quickly.
Research on HD-tDCS also suggests safety for people with brain injuries. One study found that participants using HD-tDCS showed better cognitive performance without serious side effects. Mild side effects, such as tingling on the scalp, can occur but are not harmful.
Both treatments have been studied in other trials and are considered safe for humans. However, participants should discuss any concerns with their healthcare providers before joining a trial.12345Why are researchers excited about this trial's treatments?
Researchers are excited about these trial treatments because they combine neuromodulation techniques with cognitive training to tackle traumatic brain injury (TBI) in innovative ways. Unlike standard therapies that often focus solely on cognitive rehabilitation, the trial explores the use of repetitive Transcranial Magnetic Stimulation (rTMS) and High-Definition transcranial Direct Current Stimulation (HD-tDCS) to enhance brain plasticity and recovery. These neuromodulation methods deliver non-invasive brain stimulation, potentially offering faster and more effective recovery by directly targeting brain regions involved in attention and cognitive processes. This approach represents a promising shift towards integrating brain stimulation with cognitive training to improve outcomes for TBI patients.
What evidence suggests that this trial's treatments could be effective for cognitive control deficits in complex mTBI?
Research shows that repetitive transcranial magnetic stimulation (rTMS) can improve memory and thinking skills in people with traumatic brain injury (TBI). In this trial, some participants will receive active rTMS combined with cognitive exercises like Attention Process Training (APT-3), which studies indicate may enhance mental control. Additionally, high-definition transcranial direct current stimulation (HD-tDCS) has boosted thinking abilities in those with long-term TBI. Other participants in this trial will receive active HD-tDCS with APT-3. Some research also suggests that HD-tDCS can improve language skills for weeks after treatment. Overall, early findings are promising for using rTMS and HD-tDCS with APT-3 to address thinking problems from mild TBI.12678
Who Is on the Research Team?
Davin Quinn, MD
Principal Investigator
University of New Mexico
Are You a Good Fit for This Trial?
This trial is for Veterans aged 18-59 who've had a mild traumatic brain injury (TBI) with specific cognitive symptoms, and have been stable on any psychotropic meds for 2 months. They must not be pregnant, involved in TBI litigation, or have certain medical conditions like psychosis or recent substance dependence.Inclusion Criteria
Exclusion Criteria
Timeline for a Trial Participant
Screening
Participants are screened for eligibility to participate in the trial
Baseline Testing
Participants undergo demographic, neuropsychological, behavioral, and quality of life testing, as well as MRI scanning
Treatment
Participants receive 16 sessions of APT-3 with concurrent rTMS, HD-tDCS, or sham stimulation
Post-treatment
Repeat of baseline tests including neuropsychological testing, symptom assessment, and MRI
Follow-up
Participants are monitored for safety and effectiveness after treatment at 3 and 6 months
What Are the Treatments Tested in This Trial?
Interventions
- Attention Process Training
- HD-tDCS
- rTMS
Find a Clinic Near You
Who Is Running the Clinical Trial?
University of New Mexico
Lead Sponsor
The Mind Research Network
Collaborator
New Mexico VA Healthcare System
Collaborator
Minneapolis Veterans Affairs Medical Center
Collaborator
University of Minnesota
Collaborator
New Mexico Veterans Affairs Health Care System
Collaborator
The United States Department of Defense USAMRDC
Collaborator